Parent Project Muscular Dystrophy: GSK 2402968 (PRO-051)

Parent Project Muscular Dystrophy: GSK 2402968 (PRO-051): "the forty-eight week follow-up data from the phase I/IIa extension study (PRO051-02) will be presented at an oral session on April 13, 2011 during the 63rd annual meeting of the American Academy of Neurology."